MacroGenics, Inc. (MGNX) Financials

MGNX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 345.4 million 302.5 million
March 31, 2026 217.9 million 196.7 million
Dec. 31, 2025 256.8 million 201.3 million
Sept. 30, 2025 270.8 million 203.8 million

MGNX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -41.6 million 2.0 million
March 31, 2026 -36.2 million 2.6 million
Dec. 31, 2025 42.8 million 2.7 million
Sept. 30, 2025 -30.6 million 3.5 million

MGNX Net Income

No data available :(

MGNX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 173.3 million 30.1 million -
March 31, 2026 154.2 million 31.3 million 36.5 million
Dec. 31, 2025 189.9 million 70.0 million 31.6 million
Sept. 30, 2025 146.4 million - 37.0 million

MGNX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 63.6 million
March 31, 2026 63.4 million
Dec. 31, 2025 63.2 million
Sept. 30, 2025 63.3 million

MGNX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 806000 38.8 million 7.9 million -
March 31, 2026 344000 33.3 million 9.7 million -
Dec. 31, 2025 244000 32.3 million 9.2 million -
Sept. 30, 2025 426000 30.9 million 9.9 million -

MGNX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 32.8 million -
March 31, 2026 20.8 million 11.2 million
Dec. 31, 2025 41.2 million 11.8 million
Sept. 30, 2025 72.8 million 13.4 million

MGNX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

MGNX

Price: $4.11

52 week price:
1.29
5.08

Earnings Per Share: -1.64 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 382181

Ebitda: -45.8 million

Market Capitalization: 258.6 million

Links: